30%
“Time savings: Reduced workflow times by 30% through improved access to key publications”
As published on alpha-sense.com. Captured by usedby on Oct 7, 2026.
What happened
Royalty Pharma's strategy and analytics team uses AlphaSense for genAI-powered search, automated data extraction, and a shared searchable knowledge base that combines internal diligence documents with AlphaSense's content library. This supports due diligence on biopharmaceutical investment opportunities and monitoring of IP developments.
Summary written by usedby from the source page, in English. The figures are those of AlphaSense and Royalty Pharma, not ours.
Working with AlphaSense has decreased the time this team needs to work by about 30% by having access to scientific publications, regulatory documents, patents, financial information, sell side notes, broker information — and now the game-changing access to genAI over all of that.
Before AlphaSense, our analysts spent hours scanning hundreds of industry journals just to find that nugget of information that might make or break an investment thesis.
What the story claims, and what we checked
We compared the story with its live page on Oct 7, 2026.
- The figure: 30%CheckedPrinted word for word on the page, near the name of Royalty Pharma.
- The passage quoted aboveCheckedCopied word for word from the page, near the name of Royalty Pharma.
- Royalty Pharma uses AlphaSenseCheckedConfirmed line. Latest check across sources: Oct 7, 2026.
- The result itselfNot checkedWe quote it; we did not measure it.




